activL Artificial Disc
Highridge Medical, LLC · Decision date Jan 29, 2026
What did the FDA approve?
FDA records P120024/S014 as a supplement to PMA P120024, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jan 29, 2026.
FDA approval order statement
Approval of the Olive Branch Distribution Center (FEI 3016050940) as an additional facility for conducting incoming product inspections, Device History Record (DHR) documentation review, and release of finished goods into inventory for distribution of the subject device to the United States market.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Orthopedic
- Decision date
- Jan 29, 2026
- FDA change category
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P120024/S014
- Regulatory pathway
- PMA supplement
- Applicant
- Highridge Medical, LLC
- Product code
- MJO
- Decision code
- APPR
- Decision date
- Jan 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, intervertebral disc.
- Applicant
- Highridge Medical, LLC
- Product code
- MJO
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P120024/S014 received
Application receipt date recorded by FDA.
P120024/S014 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P120024. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
Other records with product code MJO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BAGUERAC Cervical Disc ProsthesisP250042/S002 | Spineart USA, Inc. | PMA supplement | Sep 22, 2026 | FDA |
Synergy DiscP250028/S003 | Synergy Spine Solutions, Inc. | PMA supplement | Sep 17, 2026 | FDA |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
prodisc C NovaP070001/S031 | Centinel Spine, LLC | PMA supplement | Sep 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Highridge Medical, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 10225 Westmoor Dr., Westminister, CO, 80021
Sources and methodology
- Original FDA record: P120024/S014
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


